AU2022223400A1 - Composite light adjustable intraocular lens with diffractive structure - Google Patents
Composite light adjustable intraocular lens with diffractive structure Download PDFInfo
- Publication number
- AU2022223400A1 AU2022223400A1 AU2022223400A AU2022223400A AU2022223400A1 AU 2022223400 A1 AU2022223400 A1 AU 2022223400A1 AU 2022223400 A AU2022223400 A AU 2022223400A AU 2022223400 A AU2022223400 A AU 2022223400A AU 2022223400 A1 AU2022223400 A1 AU 2022223400A1
- Authority
- AU
- Australia
- Prior art keywords
- diffractive
- light adjustable
- intraocular lens
- lens
- iol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 85
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 127
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 112
- 230000004438 eyesight Effects 0.000 claims abstract description 20
- 239000002318 adhesion promoter Substances 0.000 claims description 40
- 229920000642 polymer Polymers 0.000 claims description 33
- 125000000524 functional group Chemical group 0.000 claims description 30
- 238000005286 illumination Methods 0.000 claims description 30
- -1 aryl acrylate Chemical compound 0.000 claims description 28
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 21
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 19
- 229920002554 vinyl polymer Polymers 0.000 claims description 18
- 239000011159 matrix material Substances 0.000 claims description 16
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 239000000178 monomer Substances 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 229920001577 copolymer Polymers 0.000 claims description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 238000006116 polymerization reaction Methods 0.000 claims description 12
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 9
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 9
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 9
- 125000006431 methyl cyclopropyl group Chemical group 0.000 claims description 9
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 9
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 9
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims description 8
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 8
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 8
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 6
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims description 4
- 150000004678 hydrides Chemical class 0.000 claims description 4
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 4
- WRAQQYDMVSCOTE-UHFFFAOYSA-N phenyl prop-2-enoate Chemical compound C=CC(=O)OC1=CC=CC=C1 WRAQQYDMVSCOTE-UHFFFAOYSA-N 0.000 claims description 4
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 125000005336 allyloxy group Chemical group 0.000 claims description 3
- 125000000129 anionic group Chemical group 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 125000002091 cationic group Chemical group 0.000 claims description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 3
- SPIGUVVOJXSWNX-UHFFFAOYSA-N n-(oxomethylidene)thiohydroxylamine Chemical compound SN=C=O SPIGUVVOJXSWNX-UHFFFAOYSA-N 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 150000002825 nitriles Chemical class 0.000 claims description 3
- 210000000695 crystalline len Anatomy 0.000 description 228
- 230000003287 optical effect Effects 0.000 description 74
- 241000030538 Thecla Species 0.000 description 56
- 238000000034 method Methods 0.000 description 40
- 230000008901 benefit Effects 0.000 description 36
- 238000013461 design Methods 0.000 description 34
- 238000001356 surgical procedure Methods 0.000 description 27
- 238000002513 implantation Methods 0.000 description 22
- 210000001525 retina Anatomy 0.000 description 22
- 230000004075 alteration Effects 0.000 description 20
- 239000013598 vector Substances 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 16
- 239000000463 material Substances 0.000 description 16
- 208000002177 Cataract Diseases 0.000 description 14
- 238000012937 correction Methods 0.000 description 13
- 238000003780 insertion Methods 0.000 description 13
- 230000037431 insertion Effects 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 230000008569 process Effects 0.000 description 9
- 238000000926 separation method Methods 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 6
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 6
- 201000009310 astigmatism Diseases 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000002207 retinal effect Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 210000001747 pupil Anatomy 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000004971 Cross linker Substances 0.000 description 3
- 206010036346 Posterior capsule opacification Diseases 0.000 description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
- 239000011358 absorbing material Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 210000004087 cornea Anatomy 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000001542 lens epithelial cell Anatomy 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 229910000077 silane Inorganic materials 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000004304 visual acuity Effects 0.000 description 3
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- QPMLHNVAWXBESP-UHFFFAOYSA-N 3-tris[[ethenyl(dimethyl)silyl]oxy]silylpropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC[Si](O[Si](C)(C)C=C)(O[Si](C)(C)C=C)O[Si](C)(C)C=C QPMLHNVAWXBESP-UHFFFAOYSA-N 0.000 description 2
- 150000008062 acetophenones Chemical class 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- UBHZUDXTHNMNLD-UHFFFAOYSA-N dimethylsilane Chemical compound C[SiH2]C UBHZUDXTHNMNLD-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000004313 glare Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 238000010297 mechanical methods and process Methods 0.000 description 2
- 230000005226 mechanical processes and functions Effects 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000007669 thermal treatment Methods 0.000 description 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- QTKPMCIBUROOGY-UHFFFAOYSA-N 2,2,2-trifluoroethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(F)(F)F QTKPMCIBUROOGY-UHFFFAOYSA-N 0.000 description 1
- VBHXIMACZBQHPX-UHFFFAOYSA-N 2,2,2-trifluoroethyl prop-2-enoate Chemical compound FC(F)(F)COC(=O)C=C VBHXIMACZBQHPX-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- JJBFVQSGPLGDNX-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)COC(=O)C(C)=C JJBFVQSGPLGDNX-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- LTHJXDSHSVNJKG-UHFFFAOYSA-N 2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOCCOC(=O)C(C)=C LTHJXDSHSVNJKG-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- FHBWGXDQIOWTCK-UHFFFAOYSA-N 2-methylpentanenitrile Chemical compound CCCC(C)C#N FHBWGXDQIOWTCK-UHFFFAOYSA-N 0.000 description 1
- RZVINYQDSSQUKO-UHFFFAOYSA-N 2-phenoxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC1=CC=CC=C1 RZVINYQDSSQUKO-UHFFFAOYSA-N 0.000 description 1
- CIRAAOJPSPDQFS-UHFFFAOYSA-N 3-[[ethenyl(dimethyl)silyl]oxy-dimethylsilyl]propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC[Si](C)(C)O[Si](C)(C)C=C CIRAAOJPSPDQFS-UHFFFAOYSA-N 0.000 description 1
- AJFWWYIMEUKGTI-UHFFFAOYSA-N 3-[[ethenyl(dimethyl)silyl]oxy-dimethylsilyl]propyl prop-2-enoate Chemical compound C=C[Si](C)(C)O[Si](C)(C)CCCOC(=O)C=C AJFWWYIMEUKGTI-UHFFFAOYSA-N 0.000 description 1
- CGLJGUWVVOZDCN-UHFFFAOYSA-N 3-[bis[[ethenyl(dimethyl)silyl]oxy]methylsilyl]propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC[SiH2]C(O[Si](C)(C)C=C)O[Si](C)(C)C=C CGLJGUWVVOZDCN-UHFFFAOYSA-N 0.000 description 1
- DRCATYMPTJJKPX-UHFFFAOYSA-N 3-[bis[[ethenyl(dimethyl)silyl]oxy]methylsilyl]propyl prop-2-enoate Chemical compound C=C[Si](C)(C)OC(O[Si](C)(C)C=C)[SiH2]CCCOC(=O)C=C DRCATYMPTJJKPX-UHFFFAOYSA-N 0.000 description 1
- CQXLSRCTHRPEOY-UHFFFAOYSA-N 3-tris[[ethenyl(dimethyl)silyl]oxy]silylpropyl prop-2-enoate Chemical compound C=C[Si](C)(C)O[Si](O[Si](C)(C)C=C)(O[Si](C)(C)C=C)CCCOC(=O)C=C CQXLSRCTHRPEOY-UHFFFAOYSA-N 0.000 description 1
- UWNKWYCXBHFDTA-UHFFFAOYSA-N 4-[[ethenyl(dimethyl)silyl]oxy-dimethylsilyl]butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCC[Si](C)(C)O[Si](C)(C)C=C UWNKWYCXBHFDTA-UHFFFAOYSA-N 0.000 description 1
- KPSLFFALYRKWDB-UHFFFAOYSA-N 4-[[ethenyl(dimethyl)silyl]oxy-dimethylsilyl]butyl prop-2-enoate Chemical compound C=C[Si](C)(C)O[Si](C)(C)CCCCOC(=O)C=C KPSLFFALYRKWDB-UHFFFAOYSA-N 0.000 description 1
- QJGBBHOVQZTKDM-UHFFFAOYSA-N 4-[bis[[ethenyl(dimethyl)silyl]oxy]methylsilyl]butyl 2-methylprop-2-enoate Chemical compound C(C(=C)C)(=O)OCCCC[SiH2]C(O[Si](C=C)(C)C)O[Si](C)(C)C=C QJGBBHOVQZTKDM-UHFFFAOYSA-N 0.000 description 1
- WXPOBWZJIMOPFJ-UHFFFAOYSA-N 4-[bis[[ethenyl(dimethyl)silyl]oxy]methylsilyl]butyl prop-2-enoate Chemical compound C(C=C)(=O)OCCCC[SiH2]C(O[Si](C=C)(C)C)O[Si](C)(C)C=C WXPOBWZJIMOPFJ-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical group FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- YKGKSKGJSHEYMC-UHFFFAOYSA-N 4-tris[[ethenyl(dimethyl)silyl]oxy]silylbutyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCC[Si](O[Si](C)(C)C=C)(O[Si](C)(C)C=C)O[Si](C)(C)C=C YKGKSKGJSHEYMC-UHFFFAOYSA-N 0.000 description 1
- YKGYTXALERAVCJ-UHFFFAOYSA-N 4-tris[[ethenyl(dimethyl)silyl]oxy]silylbutyl prop-2-enoate Chemical compound C=C[Si](C)(C)O[Si](O[Si](C)(C)C=C)(O[Si](C)(C)C=C)CCCCOC(=O)C=C YKGYTXALERAVCJ-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 208000010415 Low Vision Diseases 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- HMDDXIMCDZRSNE-UHFFFAOYSA-N [C].[Si] Chemical compound [C].[Si] HMDDXIMCDZRSNE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical compound C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000021921 corneal disease Diseases 0.000 description 1
- 201000004573 corneal ectasia Diseases 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N desyl alcohol Natural products C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 238000006459 hydrosilylation reaction Methods 0.000 description 1
- GJIDOLBZYSCZRX-UHFFFAOYSA-N hydroxymethyl prop-2-enoate Chemical compound OCOC(=O)C=C GJIDOLBZYSCZRX-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- UIUXUFNYAYAMOE-UHFFFAOYSA-N methylsilane Chemical compound [SiH3]C UIUXUFNYAYAMOE-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical class [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000003186 pharmaceutical solution Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 208000014733 refractive error Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000007627 surgical diagnostic procedure Methods 0.000 description 1
- 125000006442 t-butyl cyclopropyl group Chemical group 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1654—Diffractive lenses
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/16965—Lens includes ultraviolet absorber
- A61F2002/1699—Additional features not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0053—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in optical properties
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C2202/00—Generic optical aspects applicable to one or more of the subgroups of G02C7/00
- G02C2202/14—Photorefractive lens material
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C2202/00—Generic optical aspects applicable to one or more of the subgroups of G02C7/00
- G02C2202/16—Laminated or compound lenses
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C2202/00—Generic optical aspects applicable to one or more of the subgroups of G02C7/00
- G02C2202/20—Diffractive and Fresnel lenses or lens portions
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Transplantation (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/180,790 US20210251744A1 (en) | 2017-05-29 | 2021-02-21 | Composite light adjustable intraocular lens with diffractive structure |
| US17/180,790 | 2021-02-21 | ||
| PCT/US2022/016131 WO2022177821A1 (fr) | 2021-02-21 | 2022-02-11 | Lentille intraoculaire composite réglable par la lumière à structure diffractive |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2022223400A1 true AU2022223400A1 (en) | 2023-08-10 |
| AU2022223400A9 AU2022223400A9 (en) | 2024-05-09 |
Family
ID=82931086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022223400A Pending AU2022223400A1 (en) | 2021-02-21 | 2022-02-11 | Composite light adjustable intraocular lens with diffractive structure |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4294325A1 (fr) |
| JP (1) | JP2024507815A (fr) |
| CN (1) | CN116867464A (fr) |
| AU (1) | AU2022223400A1 (fr) |
| CA (1) | CA3208477A1 (fr) |
| WO (1) | WO2022177821A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115721448B (zh) * | 2022-11-22 | 2023-10-31 | 无锡蕾明视康科技有限公司 | 一种全视程型人工晶状体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8222360B2 (en) * | 2009-02-13 | 2012-07-17 | Visiogen, Inc. | Copolymers for intraocular lens systems |
| US9622855B2 (en) * | 2012-10-08 | 2017-04-18 | Valdemar Portney | Remote multifocal to monofocal optic conversion |
| US9335564B2 (en) * | 2014-05-15 | 2016-05-10 | Novartis Ag | Multifocal diffractive ophthalmic lens using suppressed diffractive order |
| US10966819B2 (en) * | 2017-05-29 | 2021-04-06 | Rxsight, Inc. | Composite light adjustable intraocular lens |
-
2022
- 2022-02-11 CA CA3208477A patent/CA3208477A1/fr active Pending
- 2022-02-11 JP JP2023549927A patent/JP2024507815A/ja active Pending
- 2022-02-11 EP EP22756734.4A patent/EP4294325A1/fr active Pending
- 2022-02-11 CN CN202280016092.5A patent/CN116867464A/zh active Pending
- 2022-02-11 WO PCT/US2022/016131 patent/WO2022177821A1/fr active Application Filing
- 2022-02-11 AU AU2022223400A patent/AU2022223400A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024507815A (ja) | 2024-02-21 |
| AU2022223400A9 (en) | 2024-05-09 |
| CA3208477A1 (fr) | 2022-08-25 |
| CN116867464A (zh) | 2023-10-10 |
| WO2022177821A1 (fr) | 2022-08-25 |
| EP4294325A1 (fr) | 2023-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10966819B2 (en) | Composite light adjustable intraocular lens | |
| US20210251744A1 (en) | Composite light adjustable intraocular lens with diffractive structure | |
| CN106554506B (zh) | 通过诱导靶向量的非球面性，使用光可调节的透镜(lal)增加聚焦深度 | |
| AU2011317283B2 (en) | Vision correction system | |
| JP2009532176A (ja) | 遠近調節を備えた眼内レンズ | |
| JP2007503850A (ja) | 光調節可能な多焦点レンズ | |
| JP2005506875A (ja) | 変形可能な眼内多焦点レンズ | |
| EP2552353A2 (fr) | Système de lentille intraoculaire ajustable | |
| CA3152304A1 (fr) | Accommodation de lentilles intraoculaires a surface torique | |
| AU2022223400A9 (en) | Composite light adjustable intraocular lens with diffractive structure | |
| JP2021506420A (ja) | 改善された支持部力分布を有する眼内レンズプラットフォーム | |
| US20210322152A1 (en) | Composite light adjustable intraocular lens with adhesion promoter | |
| EP1299051B1 (fr) | Lentille endo-capsulaire complementaire | |
| JP2008544819A (ja) | 適合可能な支持部構造を有する折り畳み可能な眼内レンズ | |
| AU2001259602A1 (en) | Supplementary endo-capsular lens and method of implantation | |
| JP2004535251A (ja) | 小切開レンズ及びその使用方法 | |
| US20220296363A1 (en) | Accommodative Intraocular Lens Combination with Independent Fixed and Variable Power Lens Sections | |
| WO2020146177A2 (fr) | Procédé d'ajustement d'une profondeur étendue mixte de lentille ajustable par la lumiere à axes décalés latéralement | |
| Packer et al. | Pseudoaccommodative and Accommodative IOLs | |
| KR20070054219A (ko) | 조정 가능한 지지부를 구비한 접을 수 있는 안 내부 렌즈 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SREP | Specification republished |